Six experts resign from Trump HIV/AIDS panel

June 19, 2017

Six top health advisors have resigned from Donald Trump's advisory council on HIV/AIDS, complaining that the US president doesn't really care about combatting the illness.

In a letter published Friday in Newsweek, Scott Schoettes said the Trump administration has "no strategy" on AIDS and that he and his five colleagues will be more effective advocating for change from the outside.

Schoettes, counsel and HIV project director at Lambda Legal, resigned Tuesday from the Presidential Advisory Council on HIV/AIDS, along with Lucy Bradley-Springer, Gina Brown, Ulysses Burley III, Michelle Ogle and Grissel Granados.

The council can have up to 25 members.

"The Trump administration has no strategy to address the on-going HIV/AIDS epidemic, seeks zero input from experts to formulate HIV policy, and—most concerning—pushes legislation that will harm people living with HIV and halt or reverse important gains made in the fight against this disease," Schoettes wrote.

"If we do not ensure that US leadership at the executive and legislative levels are informed by experience and expertise, real people will be hurt and some will even die," he said.

"Because we do not believe the Trump administration is listening to—or cares—about the communities we serve as members of PACHA, we have decided it is time to step down."

PACHA, which was created in 1995, includes , researchers, , faith leavers, HIV advocates and people living with HIV. Its helps inform the National HIV/AIDS Strategy, which was last revised in 2015.

Schoettes noted that Trump failed to appoint a head of the White House Office of National AIDS Policy, a senior advisory position, and took down the Office of National AIDS Policy website the very day he took office—on January 20—and has yet to replace it.

He also stressed that changes Trump and his fellow Republicans in Congress are seeking to the sweeping care reform initiated by former president Barack Obama would be "extremely harmful" to people living with HIV or AIDS.

Schoettes cited data showing that only 40 percent of people living with HIV in the United States can access life-saving medications.

Explore further: National Archives to White House: Save all Trump tweets

Related Stories

National Archives to White House: Save all Trump tweets

April 3, 2017
The National Archives and Records Administration has told the White House to keep each of President Donald Trump's tweets, even those he deletes or corrects, and the White House has agreed.

Trump signs NASA bill, ponders sending Congress to space (Update 3)

March 21, 2017
President Donald Trump signed legislation Tuesday adding human exploration of Mars to NASA's mission. Could sending Congress into space be next?

The health consequences of Trump's global gag order

May 19, 2017
President Donald Trump recently signed an executive order that media reports say could obstruct nearly US$8.8 billion the U.S. spends annually to fight deadly diseases abroad. Here, Maureen Miller, a Columbia University Medical ...

Trump doesn't rule out 'amended' Obamacare: WSJ

November 11, 2016
US President-elect Donald Trump has said he will consider an "amended" version of Barack Obama's signature health care law—a sign of a shift in position after repeatedly vowing on the campaign trail that he would repeal ...

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.